Your browser doesn't support javascript.
loading
Analysis of the direct and indirect costs of treatment of imported malaria in the Slovak Republic / Análise dos custos diretos e indiretos do tratamento da malária importada na República Eslovaca
Svihrova, Viera; Szilagyiova, Maria; Krkoska, Dusan; Simekova, Katarina; Hudeckova, Henrieta; Avdicova, Maria.
  • Svihrova, Viera; Comenius University. Jessenius Faculty of Medicine. Institute of Public Health. SK
  • Szilagyiova, Maria; Comenius University. Jessenius Faculty of Medicine. Clinic of Infectology and Travel Medicine. SK
  • Krkoska, Dusan; Comenius University. Jessenius Faculty of Medicine. Clinic of Infectology and Travel Medicine. SK
  • Simekova, Katarina; Comenius University. Jessenius Faculty of Medicine. Clinic of Infectology and Travel Medicine. SK
  • Hudeckova, Henrieta; Comenius University. Jessenius Faculty of Medicine. Institute of Public Health. SK
  • Avdicova, Maria; Regional Institute of Public Health. SK
Rev. Soc. Bras. Med. Trop ; 42(4): 377-380, July-Aug. 2009. tab
Article in English | LILACS | ID: lil-527176
ABSTRACT
This study analyzed the approximate cost of treatment of patients hospitalized with a diagnosis of imported malaria in Slovakia. Between 2003 and 2007, 15 patients with imported malaria were hospitalized. The mean direct cost of the treatment was 970.75 euros and the mean indirect cost was 53.15 euros. For the patient with the highest cost of treatment, the use of mefloquine prophylaxis would have represented only 0.5 percent of the total direct cost of treating the disease. Despite the partial resistance of plasmodia, malaria chemoprophylaxis is unequivocally a cheaper choice than subsequent treatment of malaria.
RESUMO
Análise do custo aproximado do tratamento dos doentes hospitalizados na Eslováquia com malária importada. Entre 2003 a 2007, foram internados 15 doentes com malária importada. Os custos médios diretos do tratamento foram avaliados em 920,75 euros e indireto em 53,15 euros. No doente com o custo mais elevado de tratamento, a utilização da profilaxia com mefloquina representaria somente 0,5 por cento do total dos custos diretos do tratamento da doença. Apesar da resistência parcial do plasmódio, a quimioprofilaxia da malária é inequivocamente uma opção mais econômica do que o tratamento posterior da malária.
Subject(s)

Full text: Available Index: LILACS (Americas) Main subject: Mefloquine / Health Care Costs / Malaria / Antimalarials Type of study: Health economic evaluation Limits: Animals / Female / Humans / Male Country/Region as subject: Europa Language: English Journal: Rev. Soc. Bras. Med. Trop Journal subject: Tropical Medicine Year: 2009 Type: Article Affiliation country: Slovakia Institution/Affiliation country: Comenius University/SK / Regional Institute of Public Health/SK

Similar

MEDLINE

...
LILACS

LIS

Full text: Available Index: LILACS (Americas) Main subject: Mefloquine / Health Care Costs / Malaria / Antimalarials Type of study: Health economic evaluation Limits: Animals / Female / Humans / Male Country/Region as subject: Europa Language: English Journal: Rev. Soc. Bras. Med. Trop Journal subject: Tropical Medicine Year: 2009 Type: Article Affiliation country: Slovakia Institution/Affiliation country: Comenius University/SK / Regional Institute of Public Health/SK